Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Institute of Pathophysiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Front Immunol. 2023 Oct 2;14:1257422. doi: 10.3389/fimmu.2023.1257422. eCollection 2023.
Fever and hypothermia represent two opposite strategies for fighting systemic inflammation. Fever results in immune activation; hypothermia is associated with energy conservation. Systemic Inflammatory Response Syndrome (SIRS) remains a significant cause of mortality worldwide. SIRS can lead to a broad spectrum of clinical symptoms but importantly, patients can develop fever or hypothermia. During infection, polymorphonuclear cells (PMNs) such as neutrophils prevent pathogen dissemination through the formation of neutrophil extracellular traps (NETs) that ensnare and kill bacteria. However, when dysregulated, NETs also promote host tissue damage. Herein, we tested the hypothesis that temperature modulates NETs homeostasis in response to infection and inflammation. NETs formation was studied in response to infectious (, ) and sterile (mitochondria) agents. When compared to body temperature (37°C), NETs formation increased at 40°C; interestingly, the response was stunted at 35°C and 42°C. While CD16+ CD49d+ PMNs represent a small proportion of the neutrophil population, they formed ~45-85% of NETs irrespective of temperature. Temperature increased formyl peptide receptor 1 (FPR1) expression to a differential extent in CD16+ CD49d- . CD49d+ PMNSs, suggesting further complexity to neutrophil function in hypo/hyperthermic conditions. The capacity of NETs to induce Toll-like receptor 9 (TLR9)-mediated NF-κB activation was found to be temperature independent. Interestingly, NET degradation was enhanced at higher temperatures, which corresponded with greater plasma DNase activity in response to temperature increase. Collectively, our observations indicate that NETs formation and clearance are enhanced at 40°C whilst temperatures of 35°C and 42°C attenuate this response. Targeting PMN-driven immunity may represent new venues for intervention in pathological inflammation.
发热和低体温代表了对抗全身炎症的两种相反策略。发热导致免疫激活;低体温与能量节约有关。全身炎症反应综合征(SIRS)仍然是全球范围内导致死亡率的重要原因。SIRS 可导致广泛的临床症状,但重要的是,患者可能会出现发热或低体温。在感染过程中,多形核细胞(PMN)如中性粒细胞通过形成中性粒细胞胞外陷阱(NETs)来阻止病原体的传播,NETs 可以捕获和杀死细菌。然而,当 NETs 失调时,也会促进宿主组织损伤。在此,我们检验了以下假说,即温度调节感染和炎症时 NETs 的动态平衡。研究了感染(,)和无菌(线粒体)因子对 NETs 形成的影响。与体温(37°C)相比,在 40°C 时 NETs 的形成增加;有趣的是,在 35°C 和 42°C 时,反应受到阻碍。虽然 CD16+ CD49d+ PMNs 仅占中性粒细胞群体的一小部分,但无论温度如何,它们形成了约 45-85%的 NETs。温度以不同的程度增加了 CD16+ CD49d- 中的形式肽受体 1(FPR1)表达。CD49d+ PMNSs,这表明在低/高温条件下中性粒细胞功能更为复杂。NETs 诱导 Toll 样受体 9(TLR9)介导的 NF-κB 激活的能力与温度无关。有趣的是,在较高温度下 NETs 的降解增强,这与对温度升高的反应中血浆 DNA 酶活性的增加相对应。总的来说,我们的观察表明,在 40°C 时 NETs 的形成和清除增强,而 35°C 和 42°C 的温度会减弱这种反应。针对 PMN 驱动的免疫可能代表病理性炎症干预的新途径。